1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
Follow herombopag: new trials by email Literature Review of herombopag trials Research Report on herombopag
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer herombopag - Thrombopenia, Cervical Cancer | Phase 2 | Not yet recruiting | Peking University Cancer Hospital & Institute | 30 | 2025-01-01 | 2024-12-20 |
| Herombopag Added to Cyclosporine in Non Severe Aplastic Anemia Herombopag - Non Severe Aplastic Anemia, Untreated | Phase 2 | Completed | Institute of Hematology & Blood Diseases Hospital, China | 54 | 2022-12-01 | 2025-08-05 |
| Herombopag for Chemotherapy-induced Thrombocytopenia Herombopag - Chemotherapy-induced Thrombocytopenia, Herombopag | Phase 2 | Recruiting | Institute of Hematology & Blood Diseases Hospital, China | 50 | 2022-03-14 | 2025-02-24 |
Radiation Injuries (1) · Thrombocytopenia (1) · Uterine Cervical Neoplasms (1)
Institute of Hematology & Blood Diseases Hospital, China (2) · Peking University Cancer Hospital & Institute (1)
China (3)
Lei Zhang, MD (1) · Xiaofan Li, Dr (1)
PMID 19144680, PMID 20110050, PMID 2110385, PMID 26187614, PMID 29248399, PMID 29622384, PMID 30156363, PMID 30764783, PMID 30915164, PMID 33632264, PMID 41489450, PMID 8201386, PMID 9043028